SCHEMBL7085778

SCHEMBL7085778

NCCCCC1(c2ccccc2)C2CC3CC(C2)CC1C3

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 14/20 0.54
GRIN2D O15399 4/20 0.41
GRIN3B O60391 4/20 0.41
GRIN1 Q05586 4/20 0.41
GRIN2A Q12879 4/20 0.41
GRIN2B Q13224 4/20 0.41
GRIN2C Q14957 4/20 0.41
GRIN3A Q8TCU5 4/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GRIA1 P42261 2/20 0.37
GRIA2 P42262 2/20 0.37
GRIA3 P42263 2/20 0.37
GRIA4 P48058 2/20 0.37
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7083350 0.98 HSD11B1 (0.53) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7078034 0.95 HSD11B1 (0.55) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL7082030 0.94 HSD11B1 (0.54) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6680933 0.88 HSD11B1 (0.58) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL6680846 0.87 HSD11B1 (0.57) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6897711 0.81 HSD11B1 (0.62) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL6894594 0.80 HSD11B1 (0.60) HSD11B1MEN1KMT2AMAOA
SCHEMBL7082807 0.79 HSD11B1 (0.38) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL6684564 0.78 HSD11B1 (0.63) HSD11B1MEN1KMT2A
SCHEMBL7082431 0.78 HSD11B1 (0.38) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO claimed
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO disclosed